UNSPSC 51263138: Acebutolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C18H28N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 67P356D8GH, chemically known as butanamide, n-(3-acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)-,monohydrochloride,( -)- but generally known as acebutolol, which bears US NIH Compound Identifier 1978. Acebutolol most often comes in forms base, azide, hydrochloride, and methylboronate.

UNSPSC 51263138 Acebutolol is a Commodity code that shows minimal relevant recent activity in state and local procurement. The single opportunity tagged to this code—Seminole County, Florida's IFB for Naloxone and Safe Drug Deactivation Systems—does not align with acebutolol, a beta-blocker pharmaceutical used for hypertension and angina. Naloxone is an opioid antagonist, and safe drug deactivation systems are harm-reduction equipment, neither of which falls within the scope of acebutolol procurement. The mismatch suggests either a tagging error in the source or that acebutolol is not currently being solicited by state and local governments through standard procurement channels.

No relevant recent opportunities support activity under this code. Buyers evaluating acebutolol as a pharmaceutical procurement category should monitor broader pharmaceutical commodity codes or conduct direct outreach to state health departments, county health services, and municipal health agencies to assess demand.